The biggest innovation you can make is a better decision.
Aetion Evidence Platform® delivers real-world evidence for life sciences companies, payers, and at-risk providers. We help you answer the high-stakes questions in health care: what works best, for whom, and when. Because better answers lead to better decisions.Learn more
ICER to use Aetion observational RWE to update value assessment of treatments for hereditary angioedema
ICER and Aetion will work together to generate RWE to inform value reassessments for three hereditary angioedema treatments, a continuation of our existing collaboration to advance the use of RWE in HTA.Learn more
ISPE Mid-Year Virtual Meeting
On Tuesday, April 20, at 8:15 a.m. ET, join our Co-Founder, President, and Chief Science Officer Jeremy Rassen for the session “Rise of the machines: Big data analytics and machine learning in pharmacoepidemiology” at the ISPE Mid-Year Virtual Meeting.Learn more
The Evidence Hub
Want to learn more about real-world evidence? Read up on perspectives, milestones, and best practices in real-world evidence and value-based health care on our blog, the Evidence Hub.Read more
Scientific rigor for real-world evidence solutions
As a partner to the majority of the top 20 global biopharma firms, leading payers, and the FDA, Aetion informs the most critical decisions in the industry. Our transparent analyses guide product development, commercialization, and payment innovation into health care’s modern era.
Rapid answers for decisions that matter
Aetion Evidence Platform moves the application of real-world evidence from descriptive analytics to causal conclusions. And it delivers answers within days and weeks—the rapid results needed to improve clinical and financial outcomes. Turn your best available information into insights you can use now.
Trusted real -world evidence for all stakeholders
Our solutions begin with asking the right question and determining the right data from our commercial and academic partners around the world. Then, the analytic workflows of the platform—meeting and setting international scientific standards—enable you to validate assumptions and align stakeholders. Including on value-based care imperatives such as outcomes-based contracting.
Aetion Evidence Platform has been tremendous for us with regards to delivering RWE more efficiently. From an operational perspective, it has helped us generate high quality evidence faster, and allows us to deliver more for our stakeholders.
The most intriguing part of the Aetion story is the ability to have a very consistent analytic approach that can be applied across multiple data sets.
Aetion’s rapid turn-around time is critical, as is the fact that their analyses are based on our membership. By using predictive modeling to identify high-risk patients—who will become high-cost—we’re able to quickly engage with providers and health systems to intervene early. This improves outcomes for our highest-risk patient populations.
As part of our digital business transformation, we believe that strategic partnerships will advance our capabilities for rapid analytics. The Aetion Evidence Platform has helped reduce the completion time for UCB’s RWE initiatives by 50%, and has enhanced our capabilities to run multiple concurrent studies.
News & Events
News & Events
The Evidence Base
ICER pilot project to use real-world evidence in hereditary angioedema treatments value assessment update
Accelerated approval, real-world evidence pilot from ICER, Aetion picks HAE as first therapeutic area
DIA 2021 Virtual Global Annual Meeting
Update on FDA’s vision on real-world evidence: Current FDA projects
2021 AcademyHealth Annual Research Meeting
The changing nature of evidence
The Evidence Digest
Subscribe to our newsletter for insights and updates on research and applications for real-world evidence in life sciences and value-based health care.